Value through Innovation27 July 2016

Clinical Study Results

  • BIBP 5371 - Healthy
    Clinical Study Number 1214.1
    Study Indication Healthy
    Product BIBP 5371
    Generic Name BIBP 5371
    Lab Code
    Clinical Phase I
    Study Title

    Safety, tolerability and pharmacokinetics of BIBP 5371 CL followingoral administration to healthy male and female volunteers (dose range:10 – 350 mg). A double-blind (within treatment groups), randomised,placebo-controlled, single rising dose study, including comparisons of50 mg vs. 100 mg tablet and tablet vs. drinking solution, andinvestigation of food effect.

    Study Document Trial synopsis 1214.1 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.